Seattle Genetics Inc.

NAS: SGEN

GO
/marketstate/country/us

Market open

 --Real time quotes

Jul 6, 2020, 2:01 p.m.

/zigman2/quotes/203326163/composite

$

171.02

Change

+1.99 +1.18%

Volume

Volume 441,489

Real time quotes

/zigman2/quotes/203326163/composite

Previous close

$ 169.03

$ 171.02

Change

+1.99 +1.18%

Day low

Day high

$169.62

$172.30

Open

52 week low

52 week high

$63.02

$175.64

Open

Insider Actions for Seattle Genetics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/01/2020 Todd E. Simpson
Chief Financial Officer
1,010   Disposition at $171.39 per share. 173,103
07/01/2020 Todd E. Simpson
Chief Financial Officer
139   Disposition at $170.18 per share. 23,655
07/01/2020 Todd E. Simpson
Chief Financial Officer
5,012   Disposition at $167.66 per share. 840,311
07/01/2020 Todd E. Simpson
Chief Financial Officer
4,112   Disposition at $166.99 per share. 686,662
07/01/2020 Todd E. Simpson
Chief Financial Officer
1,300   Disposition at $165.86 per share. 215,618
06/19/2020 Jean I. Liu
GC/EVP, Leg Affairs
9,877   Disposition at $165 per share. 1,629,705
06/17/2020 Roger D. Dansey
Chief Medical Officer
962   Disposition at $160.1 per share. 154,016
06/17/2020 Roger D. Dansey
Chief Medical Officer
300   Disposition at $158.47 per share. 47,541
06/17/2020 Roger D. Dansey
Chief Medical Officer
900   Disposition at $157.74 per share. 141,966
06/16/2020 Roger D. Dansey
Chief Medical Officer
838   Disposition at $157.15 per share. 131,691
06/15/2020 Roger D. Dansey
Chief Medical Officer
4,984   Disposition at $157.15 per share. 783,235
06/08/2020 Clay B. Siegall
President and CEO; Director
2,700   Disposition at $145.03 per share. 391,581
06/08/2020 Clay B. Siegall
President and CEO; Director
2,300   Disposition at $146.07 per share. 335,961
06/08/2020 Clay B. Siegall
President and CEO; Director
3,500   Disposition at $147 per share. 514,500
06/08/2020 Clay B. Siegall
President and CEO; Director
2,800   Disposition at $148.12 per share. 414,736
06/08/2020 Clay B. Siegall
President and CEO; Director
4,635   Disposition at $148.85 per share. 689,919
06/08/2020 Clay B. Siegall
President and CEO; Director
5,937   Disposition at $150.23 per share. 891,915
06/08/2020 Clay B. Siegall
President and CEO; Director
6,600   Disposition at $151.09 per share. 997,194
06/08/2020 Clay B. Siegall
President and CEO; Director
2,700   Derivative/Non-derivative trans. at $12 per share. 32,400
06/08/2020 Clay B. Siegall
President and CEO; Director
2,300   Derivative/Non-derivative trans. at $12 per share. 27,600
06/08/2020 Clay B. Siegall
President and CEO; Director
3,500   Derivative/Non-derivative trans. at $12 per share. 42,000
06/08/2020 Clay B. Siegall
President and CEO; Director
2,800   Derivative/Non-derivative trans. at $12 per share. 33,600
06/08/2020 Clay B. Siegall
President and CEO; Director
4,635   Derivative/Non-derivative trans. at $12 per share. 55,620
06/08/2020 Clay B. Siegall
President and CEO; Director
5,937   Derivative/Non-derivative trans. at $12 per share. 71,244
06/08/2020 Clay B. Siegall
President and CEO; Director
6,600   Derivative/Non-derivative trans. at $12 per share. 79,200
05/15/2020 Baker Bros. Advisors LP
Director
1,335   Award at $0 per share. 0
05/15/2020 Baker Bros. Advisors LP
Director
1,335   Award at $0 per share. 0
05/15/2020 Marc E. Lippman
Director
1,335   Award at $0 per share. 0
05/15/2020 Daniel G. Welch
Director
1,335   Award at $0 per share. 0
05/15/2020 Charles R. Romp
EVP, Commercial
3,444   Award at $0 per share. 0
05/15/2020 David W. Gryska
Director
1,335   Award at $0 per share. 0
05/15/2020 Srinivas Akkaraju
Director
1,335   Award at $0 per share. 0
05/15/2020 Nancy A. Simonian
Director
1,335   Award at $0 per share. 0
05/15/2020 John A. Orwin
Director
1,335   Award at $0 per share. 0
05/15/2020 Alpna H. Seth
Director
1,335   Award at $0 per share. 0
05/15/2020 Baker Bros. Advisors LP
Director
1,602,312   Disposition at $160 per share. 256,369,920
05/15/2020 Baker Bros. Advisors LP
Director
147,688   Disposition at $160 per share. 23,630,080
05/12/2020 Charles R. Romp
EVP, Commercial
6,942   Disposition at $166 per share. 1,152,372
05/12/2020 Charles R. Romp
EVP, Commercial
6,942   Derivative/Non-derivative trans. at $15.46 per share. 107,323
05/08/2020 Clay B. Siegall
President and CEO; Director
1,100   Disposition at $163.5 per share. 179,850
05/08/2020 Clay B. Siegall
President and CEO; Director
3,549   Disposition at $162.68 per share. 577,351
05/08/2020 Clay B. Siegall
President and CEO; Director
5,355   Disposition at $161.74 per share. 866,117
05/08/2020 Clay B. Siegall
President and CEO; Director
8,204   Disposition at $160.72 per share. 1,318,546
05/08/2020 Clay B. Siegall
President and CEO; Director
10,264   Disposition at $160.02 per share. 1,642,445
05/08/2020 Charles R. Romp
EVP, Commercial
6,942   Disposition at $163.02 per share. 1,131,684
05/08/2020 Clay B. Siegall
President and CEO; Director
1,100   Derivative/Non-derivative trans. at $12 per share. 13,200
05/08/2020 Clay B. Siegall
President and CEO; Director
3,549   Derivative/Non-derivative trans. at $12 per share. 42,588
05/08/2020 Clay B. Siegall
President and CEO; Director
5,355   Derivative/Non-derivative trans. at $12 per share. 64,260
05/08/2020 Clay B. Siegall
President and CEO; Director
8,204   Derivative/Non-derivative trans. at $12 per share. 98,448
05/08/2020 Clay B. Siegall
President and CEO; Director
10,264   Derivative/Non-derivative trans. at $12 per share. 123,168
05/08/2020 Charles R. Romp
EVP, Commercial
6,942   Derivative/Non-derivative trans. at $15.46 per share. 107,323
05/07/2020 Baker Bros. Advisors LP
Director
4,343   Disposition at $166.15 per share. 721,589
05/07/2020 Baker Bros. Advisors LP
Director
400   Disposition at $166.15 per share. 66,460
05/07/2020 Baker Bros. Advisors LP
Director
48,880   Disposition at $164.96 per share. 8,063,244
05/07/2020 Baker Bros. Advisors LP
Director
4,505   Disposition at $164.96 per share. 743,144
05/07/2020 Baker Bros. Advisors LP
Director
84,663   Disposition at $164.19 per share. 13,900,817
05/07/2020 Baker Bros. Advisors LP
Director
7,805   Disposition at $164.19 per share. 1,281,502
05/07/2020 Baker Bros. Advisors LP
Director
16,159   Disposition at $163.41 per share. 2,640,542
05/07/2020 Baker Bros. Advisors LP
Director
1,489   Disposition at $163.41 per share. 243,317
05/07/2020 Roger D. Dansey
Chief Medical Officer
11,912   Disposition at $164.5 per share. 1,959,524
05/07/2020 Roger D. Dansey
Chief Medical Officer
11,912   Derivative/Non-derivative trans. at $65.11 per share. 775,590

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
50 Purchases
78 Sales
224,284
2,596,195
Last 6 months
68 Purchases
98 Sales
335,200
2,690,688
Last 12 months
114 Purchases
153 Sales
731,421
3,048,624

Officers and Executives

Dr. Clay B. Siegall
Chairman, President & Chief Executive Officer
Mr. Todd E. Simpson
Chief Financial Officer
Dr. Vaughn B. Himes
Chief Technical Officer
Dr. Robert J. Lechleider
Senior Vice President-Clinical Development
Dr. Roger D. Dansey
Chief Medical Officer
Dr. Robin G. Taylor
Chief Commercial Officer
Dr. Peter D. Senter
Vice President-Chemistry
Ms. Natasha A. Hernday
Senior Vice President-Corporate Development
Dr. Dennis Benjamin
Senior Vice President-Translational Research
Ms. Peggy Pinkston
Vice President-Investor Relations
Mr. Christopher Pawlowicz
Executive Vice President-Human Resources
Ms. Jean I. Liu
Executive VP-Legal Affairs & General Counsel
Dr. Srinivas Akkaraju
Independent Director
Dr. Marc E. Lippman
Independent Director
Dr. Felix James Baker
Lead Independent Director
Mr. David W. Gryska
Independent Director
Dr. Nancy A. Simonian
Independent Director
Mr. John A. Orwin
Independent Director
Mr. Daniel G. Welch
Independent Director
Dr. Alpna H. Seth
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.